Efficient bioconversion of compactin to pravastatin by the quinoline-degrading microorganism Pseudonocardia carboxydivorans isolated from petroleum-contaminated soil

Bioresource Technology

Volumn 102, Issue 22, 2011, Pages 10187-10193

  Lin, Chung Liang ^a,b   Tang, Ya Li ^c   Lin, Shyh Mirn ^c  

^a CPC CORPORATION   (Taiwan)

^b Chung Hwa University of Medical Technology ^*  (Taiwan)

^c CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

Author keywords

Bioconversion; Compactin; Pravastatin; Pseudonocardia carboxydivorans; Quinoline

Indexed keywords

BIOCONVERSION; GASOLINE; MICROORGANISMS; SOIL POLLUTION; STRAIN;

COMPACTIN; INDUSTRIAL SCALE; PETROLEUM-CONTAMINATED SOIL; PRAVASTATIN; PRE-INCUBATION; PSEUDONOCARDIA; QUINOLINE; UTILIZATION RATES;

BIODEGRADATION;

COMPACTIN; PETROLEUM; PRAVASTATIN; QUINOLINE;

AROMATIC HYDROCARBON; BACTERIUM; BIODEGRADATION; DRUG; IDENTIFICATION METHOD; PETROLEUM; SODIUM; SOIL MICROORGANISM; SOIL POLLUTION;

ARTICLE; ASPERGILLUS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIODEGRADATION; BIOTRANSFORMATION; DRUG TRANSFORMATION; FUSARIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INCUBATION TIME; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDONOCARDIA CARBOXYDIVORANS; PSEUDONOCARDIACEAE; SOIL POLLUTION;

PSEUDONOCARDIA; PSEUDONOCARDIA SP.;

EID: 80054832426     PISSN: 09608524     EISSN: 18732976     Source Type: Journal    
DOI: 10.1016/j.biortech.2011.09.029     Document Type: Article

References (36)

1. Akasaki Y., Matsuda S., Iwamoto Y. Progress of research in osteoarthritis. The anti-inflammatory effects of intra-articular injected statin on experimental osteoarthritis. Clin. Calcium 2009, 19:1653-1662.
2. Barrios-Gonzalez J., Miranda R.U. Biotechnological production and applications of statins. Appl. Microbiol. Biotechnol. 2010, 85:869-883.
3. Berger C., Xia F., Maurer M.H., Schwab S. Neuroprotection by pravastatin in acute ischemic stroke in rats. Brain Res. Rev. 2008, 58:48-56.
4. Bott G., Lingens F. Microbial metabolism of quinoline and related compounds. IX. Degradation of 6-hydroxyquinoline and quinoline by Pseudomonas diminuta 31/1 Fa1 and Bacillus circulans 31/2 A1. Biol. Chem. Hoppe Seyler 1991, 372:381-383.
5. Chen C.H., Hu H.Y., Cho Y.C., Hsu W.H. Screening of compactin-resistant microorganisms capable of converting compactin to pravastatin. Curr. Microbiol. 2006, 53:108-112.
6. Cui M., Chen F., Fu J., Sheng G., Sun G. Cometabolic biodegradation of quinoline's derivatives by a quinoline-degrading bacteria: Comamonas sp. strain Q10. J. Gen. Appl. Microbiol. 2003, 49:351-355.
7. de Beyer A., Lingens F. Microbial metabolism of quinoline and related compounds. XVI. Quinaldine oxidoreductase from Arthrobacter spec. Ru 61a: a molybdenum-containing enzyme catalysing the hydroxylation at C-4 of the heterocycle. Biol. Chem. Hoppe Seyler 1993, 374:101-109.
8. del Sol A.I., Nanayakkara P.W. Pravastatin: an evidence-based statin?. Expert Opin. Drug Metab. Toxicol. 2008, 4:821-825.
9. Fetzner S. Bacterial degradation of pyridine, indole, quinoline, and their derivatives under different redox conditions. Appl. Microbiol. Biotechnol. 1998, 49:237-250.
10. Fujii Y., Hirosue S., Fujii T., Matsumoto N., Agematu H., Arisawa A. Hydroxylation of oleanolic acid to queretaroic acid by cytochrome P450 from Nonomuraea recticatena. Biosci. Biotechnol. Biochem. 2006, 70:2299-2302.
11. Henssen A. Morphology and system of thermophilic actinomycetes. Arch. Microbiol. 1957, 26:373-414.
12. Hosobuchi M., Kurosawa K., Yoshikawa H. Application of computer to monitoring and control of fermentation process: microbial conversion of ML-236B Na to pravastatin. Biotechnol. Bioeng. 1993, 42:815-820.
13. Huang Y., Wang L., Lu Z., Hong L., Liu Z., Tan G.Y., Goodfellow M. Proposal to combine the genera Actinobispora and Pseudonocardia in an emended genus Pseudonocardia, and description of Pseudonocardia zijingensis sp. nov. Int. J. Syst. Evol. Microbiol. 2002, 52:977-982.
14. Kaiser J.P., Feng Y., Bollag J.M. Microbial metabolism of pyridine, quinoline, acridine, and their derivatives under aerobic and anaerobic conditions. Microbiol. Rev. 1996, 60:483-498.
15. Lin Q., Wang J.L. Biodegradation characteristics of quinoline by Pseudomonas putida. Bioresour. Technol. 2010, 101:7683-7686.
16. Lo Y.-C., Saratale G.D., Chen W.-M., Bai M.-D., Chang J.-S. Isolation of cellulose-hydrolytic bacteria and applications of the cellulolytic enzymes for cellulosic biohydrogen production. Enzyme Microbiol. Technol. 2009, 44:417-425.
17. Manzoni M., Rollini M. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl. Microbiol. Biotechnol. 2002, 58:555-564.
18. Matsuoka T., Miyakoshi S., Tanzawa K., Nakahara K., Hosobuchi M., Serizawa N. Purification and characterization of cytochrome P-450sca from Streptomyces carbophilus. ML-236B (compactin) induces a cytochrome P-450sca in Streptomyces carbophilus that hydroxylates ML-236B to pravastatin sodium (CS-514), a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase. Eur. J. Biochem. 1989, 184:707-713.
19. McGown C.C., Brown N.J., Hellewell P.G., Reilly C.S., Brookes Z.L. Beneficial microvascular and anti-inflammatory effects of pravastatin during sepsis involve nitric oxide synthase III. Br. J. Anaesth. 2010, 104:183-190.
20. Montecucco F., Mach F. Update on statin-mediated anti-inflammatory activities in atherosclerosis. Semin. Immunopathol. 2009, 31:127-142.
21. Neuvonen P.J., Backman J.T., Niemi M. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin. Clin. Pharmacokinet. 2008, 47:463-474.
22. Park Joo W., Lee Joo K., Kwon Tae J., Yi Dong H., Yong I., Kang Sang M. Purification and characterization of a cytochrome P-450 from pravastatin-producing Streptomyces sp. Y-110. J. Microbiol. Biotechnol. 2001, 11:7.
23. Park J.W., Lee J.K., Kwon T.J., Yi D.H., Kim Y.J., Moon S.H., Suh H.H., Kang S.M., Park Y.I. Bioconversion of compactin into pravastatin by Streptomyces sp. Biotechnol. Lett. 2003, 25:1827-1831.
24. Park S.W., Park S.T., Lee J.E., Kim Y.M. Pseudonocardia carboxydivorans sp. nov., a carbon monoxide-oxidizing actinomycete, and an emended description of the genus Pseudonocardia. Int. J. Syst. Evol. Microbiol. 2008, 58:2475-2478.
25. Peng Y., Demain A.L. Bioconversion of compactin to pravastatin by Actinomadura sp. ATCC 55678. J. Mol. Catal. B Enzym. 2000, 10:151-156.
26. Peschke B., Lingens F. Microbial metabolism of quinoline and related compounds. XII. Isolation and characterization of the quinoline oxidoreductase from Rhodococcus spec. B1 compared with the quinoline oxidoreductase from Pseudomonas putida 86. Biol. Chem. Hoppe Seyler 1991, 372:1081-1088.
27. Serizawa N. Biocatalytic production of pravastatin, an anticholesterol drug. Stereoselective Biocatalysis 2000, 703-711. Marcel Dekker, New York. P. RN (Ed.).
28. Serizawa N., Matsuoka T. A two component-type cytochrome P-450 monooxygenase system in a prokaryote that catalyzes hydroxylation of ML-236B to pravastatin, a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Biochim. Biophys. Acta 1991, 1084:35-40.
29. Serizawa N., Nakagawa K., Hamano K., Tsujita Y., Terahara A., Kuwano H. Microbial hydroxylation of ML-236B (compactin) and monacolin K (MB-530B). J. Antibiot. (Tokyo) 1983, 36:604-607.
30. Serizawa N., Nakagawa K., Tsujita Y., Terahara A., Kuwano H., Tanaka M. 6 alpha-Hydroxy-iso-ML-236B (6 alpha-hydroxy-iso-compactin) and ML-236A, microbial transformation products of ML-236B. J. Antibiot. (Tokyo) 1983, 36:918-920.
31. Shukla O.P. Microbiological degradation of quinoline by Pseudomonas stutzeri: the coumarin pathway of quinoline catabolism. Microbios 1989, 59:47-63.
32. Sun Q., Bai Y., Zhao C., Xiao Y., Wen D., Tang X. Aerobic biodegradation characteristics and metabolic products of quinoline by a Pseudomonas strain. Bioresour. Technol. 2009, 100:5030-5036.
33. Tsujita Y., Kuroda M., Shimada Y., Tanzawa K., Arai M., Kaneko I., Tanaka M., Masuda H., Tarumi C., Watanabe Y., et al. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochim. Biophys. Acta 1986, 877:50-60.
34. Wang J.L., Wu W.Z., Zhao X. Microbial degradation of quinoline: kinetics study with Burkholderia picekttii. Biomed. Environ. Sci. 2004, 17:21-26.
35. Watanabe I., Serizawa N. Molecular approaches for production of pravastatin, a HMG-CoA reductase inhibitor: transcriptional regulation of the cytochrome p450sca gene from Streptomyces carbophilus by ML-236B sodium salt and phenobarbital. Gene 1998, 210:109-116.
36. Watanabe Y., Ito T., Shiomi M., Tsujita Y., Kuroda M., Arai M., Fukami M., Tamura A. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits. Biochim. Biophys. Acta 1988, 960:294-302.